Compare ONCO & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONCO | RETO |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 3.5M |
| IPO Year | 2022 | 2017 |
| Metric | ONCO | RETO |
|---|---|---|
| Price | $1.48 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 142.2K | 93.7K |
| Earning Date | 11-13-2025 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,223,751.00 | ★ $2,109,956.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16864.81 |
| 52 Week Low | $1.37 | $1.09 |
| 52 Week High | $88.40 | $61.50 |
| Indicator | ONCO | RETO |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 36.08 |
| Support Level | $1.51 | $1.09 |
| Resistance Level | $2.30 | $1.71 |
| Average True Range (ATR) | 0.21 | 0.26 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 0.00 | 16.48 |
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.